ro 31-8220 has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Ro 31-8220: a protein kinase C inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, X | 1 |
| Jia, D | 1 |
| Ao, J | 1 |
| Liu, H | 1 |
| Zang, Y | 1 |
| Azam, M | 1 |
| Habib, SL | 1 |
| Li, J | 1 |
| Ruan, X | 1 |
| Jia, H | 1 |
| Wang, X | 1 |
| Li, B | 1 |
1 other study available for ro 31-8220 and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia.
Topics: Animals; Cell Cycle Checkpoints; DNA Damage; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; HC | 2016 |